Sox9 and Sox10 but not BRN2 are required for Nestin expression in Human Melanoma Cells

Flammiger, A., Besch, R., Cook, A. L., Maier, T., Sturm, R. A. and Berking, C. (2009) Sox9 and Sox10 but not BRN2 are required for Nestin expression in Human Melanoma Cells. Journal of Investigative Dermatology, 129 4: 945-953. doi:10.1038/jid.2008.316


Author Flammiger, A.
Besch, R.
Cook, A. L.
Maier, T.
Sturm, R. A.
Berking, C.
Title Sox9 and Sox10 but not BRN2 are required for Nestin expression in Human Melanoma Cells
Journal name Journal of Investigative Dermatology   Check publisher's open access policy
ISSN 0022-202X
Publication date 2009-04-16
Year available 2008
Sub-type Article (original research)
DOI 10.1038/jid.2008.316
Volume 129
Issue 4
Start page 945
End page 953
Total pages 9
Editor Bergstresser, P. R.
Place of publication New York
Publisher Elsevier Science
Collection year 2009
Language eng
Subject 060403 Developmental Genetics (incl. Sex Determination)
060111 Signal Transduction
060103 Cell Development, Proliferation and Death
920102 Cancer and Related Disorders
920117 Skin and Related Disorders
C1
Abstract Nestin is an intermediate filament protein and a marker of neuroectodermal stem cells indicating multipotentiality and regenerative capability. In melanoma tissues, nestin re-expression was correlated with tumor progression.
Q-Index Code C1
Q-Index Status Confirmed Code

Document type: Journal Article
Sub-type: Article (original research)
Collections: 2009 Higher Education Research Data Collection
Institute for Molecular Bioscience - Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 28 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 31 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Tue, 10 Mar 2009, 15:30:33 EST by Cody Mudgway on behalf of Institute for Molecular Bioscience